Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (7): 607-610.doi: 10.3736/jcim20090702

• Original Clinical Research • Previous Articles     Next Articles

Considerations about treatment programs of elderly patients with hypertension

Hao Li, Long-tao Liu   

  1. Department of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
  • Received:2009-01-09 Accepted:2009-04-14 Online:2009-07-20 Published:2009-07-15
  • Contact: Long-tao Liu

Hypertension in elderly patients is a common and frequent disease which could cause stroke, heart failure and renal dysfunction. The pathogenesis of hypertension in the elderly is different from that in the young and middle-aged people, and its clinical characteristics including frequent isolated systolic hypertension, variable blood pressure, high pulse pressure, multiple complications, serious target organ damage, and so on. High prevalence, disability and mortality rates and low awareness, treatment and control rates are prominent phenomena in the elderly patients with hypertension, bring many difficulties for clinical treatment. Presently, drug therapies for elderly patients mainly include Western medicine (WM), traditional Chinese medicine (TCM), and integrated traditional Chinese and Western medicine. WM therapy has superiority in lowering blood pressure intensively with clear mechanism, but has more adverse reactions. The effects of TCM therapy are multilinked, and TCM is good at reducing side effects and improving symptoms, but TCM preparation falls behind and its hypotensive effects are weak and slow. Furthermore, more multicenter, randomized, controlled and double-blinded clinical trials with large sample are needed to identify the effects of TCM therapy. Based on combination of TCM syndrome differentiation and WM disease differentiation, treatment programs of integrated traditional Chinese and Western medicine would take advantages of both TCM and WM treatment modalities, and are worthy of being studied in the future.

Key words: Hypertension, Elderly, Integrated traditional Chinese and Western medicine, Treatment protocols

[1] Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program(SHEP). SHEP Cooperative Research Group[J]. JAMA, 1991,265(24):3255-3264
doi: 10.1001/jama.1991.03460240051027
[2] Wang W, Zhao D . Epidemiology of elderly patients with hypertension in China[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2005,24(4):246-247
王薇, 赵冬 . 中国老年人高血压的流行病学[J]. 中华老年医学杂志, 2005,24(4):246-247
[3] Chobanian AV . Clinical practice. Isolated systolic hypertension in the elderly[J]. N Engl J Med, 2007,357(8):789-796
doi: 10.1056/NEJMcp071137
[4] Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ ; National Heart,Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee.Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report[J]. JAMA, 2003,289(19):2560-2572
doi: 10.1001/jama.289.19.2560
[5] Ma WJ, Liu GZ . Characteristics of target organ damage in elderly patients with hypertension[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2005,24(4):255
马文君, 刘国仗 . 老年人高血压靶器官损害特点[J]. 中华老年医学杂志, 2005,24(4):255
[6] Ministry of Health of the People's Republic of China. Guidelines for clinical research on Chinese new herbal medicines[M]. Beijing: Medical Science and Technology Publishing House of China, 1993
中华人民共和国卫生部. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 1993
[7] Li H, Liu Y, Yu ZX, Liu JG, Liu L . Effects of Jiangya Capsule combined with nimodipine on depressurization and quality of life in elderly patients with isolated systolic hypertension[J]. Zhongguo Zhong Yi Yao Xin Xi Za Zhi, 2008,15(9):8-10
doi: 10.3969/j.issn.1005-5304.2008.09.004
李浩, 刘宇, 于振宣, 刘剑刚, 刘丽 . 降压胶囊联合尼莫地平治疗老年单纯收缩期高血压疗效及对其生活质量的影响[J]. 中国中医药信息杂志, 2008,15(9):8-10
doi: 10.3969/j.issn.1005-5304.2008.09.004
[8] Li H, Guo MD, Liu JG . The effect of Jiangya capsule combined with nimodipine on ET, CGRP and AngⅡ of spontaneous hypertensive rats[J]. Zhongguo Lao Nian Xue Za Zhi, 2007,11(27):2178-2180
李浩, 郭明冬, 刘剑刚 . 降压胶囊联合尼莫地平对自发性高血压大鼠ET、CGRP及AngⅡ水平的影响[J]. 中国老年学杂志, 2007,11(27):2178-2180
[1] Pranay Soni, Rajesh Choudhary, Surendra H. Bodakhe. Effects of a novel isoflavonoid from the stem bark of Alstonia scholaris against fructose-induced experimental cataract. Journal of Integrative Medicine, 2019, 17(5): 374-382.
[2] Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
[3] Nathalia Gomes Ribeiro de Moura, Ivan Cordovil, Arthurde Sá Ferreira. Traditional Chinese medicine wrist pulse-taking is associated with pulse waveform analysis and hemodynamics in hypertension. Journal of Integrative Medicine, 2016, 14(2): 100-113.
[4] Nouran A. Aleyeidi, Khaled S. Aseri, Shadia M. Matbouli, Albaraa A. Sulaiamani, Sumayyah A. Kobeisy. Effects of wet-cupping on blood pressure in hypertensive patients: A randomized controlled trial. Journal of Integrative Medicine, 2015, 13(6): 391-399.
[5] Kylie Connolly, Douglas Jackson, Candice Pullen, Andrew Fenning. Alpha-adrenoceptor antagonism by Crassostrea gigas oyster extract inhibits noradrenaline-induced vascular contraction in Wistar rats. Journal of Integrative Medicine, 2015, 13(3): 194-200.
[6] Ya Yuwen, Yu-qi Liu, Yan-ping Wang, Jin-gang Dai, Da-sheng Liu, Yue-xi Wang, Xue-jie Han. The add-on effect of a Chinese herbal formula for patients with resistant hypertension: Study protocol for a pilot cohort study. Journal of Integrative Medicine, 2015, 13(2): 122-128.
[7] Vamsi Reddy, Arvind Sridhar, Roberto F. Machado, Jiwang Chen. High sodium causes hypertension: Evidence from clinical trials and animal experiments. Journal of Integrative Medicine, 2015, 13(1): 1-8.
[8] Yong-hong Lian, Mei-xia Fang, Li-guo Chen. Constructing protein-protein interaction network of hypertension with blood stasis syndrome via digital gene expression sequencing and database mining. Journal of Integrative Medicine, 2014, 12(6): 476-482.
[9] Yi Chen, De-yu Fu, Yu Chen, Yan-ming He, Xiao-dong Fu, Yan-qiu Xu, Yi Liu, Xiao-tao Feng, Teng Zhang, Wen-jian Wang. Effects of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: A randomized, placebo-controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(3): 184-194.
[10] Chan Chen, Chang-xun Chen, Xi-min Wu, Rui Wang, Yi-ming Li. Effects of extracts of Radix Scrophulariae on blood pressure in spontaneously hypertensive rats and the underlying mechanisms. Journal of Chinese Integrative Medicine, 2012, 10(9): 1009-1017.
[11] Xue Qiao, Yu-fang Hao. Qualitative research of the elderly real experience of long-term adherence to Tai Chi exercise. Journal of Chinese Integrative Medicine, 2012, 10(12): 1388-1393.
[12] Tao Li-li, Lei Yan. Effects of extracts from Panax ginseng, Panax notoginseng and Ligusticum chuanxiong on expression of β-galactosidase and signal pathway p16-cyclin D/CDK-Rb in vascular smooth muscle cells. Journal of Chinese Integrative Medicine, 2012, 10(1): 76-84.
[13] Rong Fan, Feng He, Yang Wang, Guang-wei Zhong, Yun-hui Li. Changes of protein expression profile in vascular tissues of spontaneously hypertensive rats treated by a compound Chinese herbal medicine. Journal of Chinese Integrative Medicine, 2011, 9(6): 643-650.
[14] Wan-li Gu , Zai-xiang Shi, Yun-xu Yu, Yu-wei Wu, Bao-wei Lu, Ka-kit Hui . Distribution characteristics of syndrome types in essential hypertension. Journal of Chinese Integrative Medicine, 2010, 8(9): 842-847.
[15] Hao Li , Long-tao Liu, Wen-ming Zhao, Jian-gang Liu, Ming-jiang Yao, Yong-xiang Han, Yan-peng Shen, Xing-dong Liu, Li Liu, Xue-mei Wang, Lin-lin Cai, Jie Guan. Traditional Chinese versus integrative treatment in elderly patients with isolated systolic hypertension: A multicenter, randomized, double-blind controlled trial. Journal of Chinese Integrative Medicine, 2010, 8(5): 410-416.
Full text



[1] Jian-ping Liu. Design, implementation and methodological issues in cohort study. Journal of Chinese Integrative Medicine, 2008, 6(4): 331-335
[2] Xun Li, Jian-ping Liu. Chinese medicinal herbs for chronic hepatitis B. Journal of Chinese Integrative Medicine, 2008, 6(4): 336
[3] Jun-hua Zhang, Hong-cai Shang, Bo-li Zhang. How to assess the quality of systematic review and meta-analysis. Journal of Chinese Integrative Medicine, 2008, 6(4): 337-339
[4] Fan Yin . The first acupuncture center in the United States: An interview with Dr. Yao Wu Lee, Washington Acupuncture Center. Journal of Chinese Integrative Medicine, 2012, 10(5): 481-492
[5] Daniel A. Weber, Janelle M. Wheat , Geoffrey M. Currie. Cancer stem cells and the impact of Chinese herbs, isolates and other complementary medical botanicals: A review. Journal of Chinese Integrative Medicine, 2012, 10(5): 493-503
[6] Liang-ping Hu, Xiao-lei Bao. How to choose an appropriate experimental design type (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(6): 615-618
[7] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634
[8] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640
[9] Peng Fu , Xue-qiang Huang, Ai-hong Yuan, Guang Yu, Xiao-bin Mei, Ruo-lan Cu. Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 641-646
[10] Ze-long Dai, Hui Chen, Xiao-ying Wu . Relationship between cytochrome P450 2C19*17 genotype distribution platelet aggregation and bleeding risk in patients with blood stasis syndrome of coronary artery disease treated with clopidogrel. Journal of Chinese Integrative Medicine, 2012, 10(6): 647-654